The Rosamund Stone Zander Translational Neuroscience Center strives to improve the lives of all children with brain disorders by fostering timely and efficient translational research.
Our core values are to maintain scientific rigor, collaboration, transparency, objectivity, diversity, equity, inclusion, belonging and access.
We have active partnerships with dozens of patient advocacy groups to inform our objectives and collaborate on research studies.
Featured News & Events
October 2023
Rosamund Stone Zander Translational Neuroscience Center Selects Four Pilot Research Grant Awardees
The Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC) at Boston Children’s Hospital is delighted to announce the selection of this year’s RSZ TNC Pilot Research Grant awardees. The mission of the RSZ TNC is to improve the lives of children with brain disorders via timely and efficient translation of scientific research through collaboration with Boston Children's Hospital's exceptional investigators, and in partnership with the external research community. To fulfill the goal of “timely and efficient translation,” this grant aims to support translational research on neurodevelopmental disorders within the domains of Preclinical Research, Drug Discovery, Therapeutic Development, Translational Biomarkers, and Gene-based Clinical Research and Trials.
October 2023
Uncovering the genetics behind autism and CHD could improve children’s health
Cardiology and neurodevelopmental researchers have long speculated there could be genetic links that could cause both congenital heart disease (CHD) and autism spectrum disorder (ASD). A new study underway at Boston Children’s is trying to confirm any such association with the hope that new discoveries could lead to targeted treatments. Maya Chopra, MBBS, FRACP, a clinical geneticist with the hospital’s Rosamund Stone Zander Neuroscience Center, is one of its lead investigators.
November 2023
Dawson's story: The human impact of a rare condition
Dawson’s life was turned upside down in 2021, aged six, following the first of a series of seizures. In this story, his mother, RELX employee Jennifer Wells, shares her family's journey as they learned to understand and cope with Dawson’s rare form of epilepsy. She is now raising awareness, along with Elsevier's Osmosis team, to help others and to try to turn a life-changing experience into something good - and hopefully to one day find a cure.